635 related articles for article (PubMed ID: 25932951)
21. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
[TBL] [Abstract][Full Text] [Related]
22. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
23. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.
Vallejo FA; Shah SS; de Cordoba N; Walters WM; Prince J; Khatib Z; Komotar RJ; Vanni S; Graham RM
J Neurooncol; 2020 Apr; 147(2):317-326. PubMed ID: 32096068
[TBL] [Abstract][Full Text] [Related]
24. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
[TBL] [Abstract][Full Text] [Related]
25. Survival kinase genes present prognostic significance in glioblastoma.
Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
[TBL] [Abstract][Full Text] [Related]
26. Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect.
Velpula KK; Bhasin A; Asuthkar S; Tsung AJ
Cancer Res; 2013 Dec; 73(24):7277-89. PubMed ID: 24148623
[TBL] [Abstract][Full Text] [Related]
27. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.
Zhao Z; Liu Y; He H; Chen X; Chen J; Lu YC
Brain Res Bull; 2011 Oct; 86(3-4):189-94. PubMed ID: 21807073
[TBL] [Abstract][Full Text] [Related]
28. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
[TBL] [Abstract][Full Text] [Related]
29. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma.
Kim J; Han J; Jang Y; Kim SJ; Lee MJ; Ryu MJ; Kweon GR; Heo JY
Int J Oncol; 2015 Sep; 47(3):1009-16. PubMed ID: 26202438
[TBL] [Abstract][Full Text] [Related]
30. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
31. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
[TBL] [Abstract][Full Text] [Related]
32. The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme.
Ramezani S; Vousooghi N; Joghataei MT; Chabok SY
Cancer Biother Radiopharm; 2019 Aug; 34(6):345-354. PubMed ID: 31411929
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models.
Jandial R; Neman J; Lim PP; Tamae D; Kowolik CM; Wuenschell GE; Shuck SC; Ciminera AK; De Jesus LR; Ouyang C; Chen MY; Termini J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385725
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
[TBL] [Abstract][Full Text] [Related]
35. Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism.
Su X; Chen S; Lu H; Li H; Qin C
Drug Des Devel Ther; 2021; 15():2769-2781. PubMed ID: 34234410
[TBL] [Abstract][Full Text] [Related]
36. MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme.
Tasaki T; Fujita M; Okuda T; Yoneshige A; Nakata S; Yamashita K; Yoshioka H; Izumoto S; Kato A
Anticancer Res; 2016 Jul; 36(7):3571-7. PubMed ID: 27354625
[TBL] [Abstract][Full Text] [Related]
37. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
38. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
[TBL] [Abstract][Full Text] [Related]
39. Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma.
Verbovšek U; Motaln H; Rotter A; Atai NA; Gruden K; Van Noorden CJ; Lah TT
PLoS One; 2014; 9(10):e111819. PubMed ID: 25356585
[TBL] [Abstract][Full Text] [Related]
40. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]